A pharmaceutical kit and process useful for achieving prolonged immunosuppression and tumor cell elimination, wherein the kit comprises a first antibody having binding specificity for T cells and is capable of eliminating T cells in vivo; and a second antibody, having binding specificity...http://www.google.fr/patents/US5830473?utm_source=gb-gplus-shareBrevet US5830473 - Antibodies against T cells as therapeutics
